Form 4 for PHIO Phio Pharmaceuticals Corp.
Accepted 2024-06-10 00:00:00 ET · period of report 2024-06-06 · accession 0001683168-24-004089 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-10 | 2024-06-06 | PHIO | Bitterman Robert J | Pres, CEO, Dir | P - Purchase | $0.75 | +1,000 | 20.0K | +5% | +$750 |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, $0.0001 par value | 2024-06-06 | P | A | 1,000 | $0.75 | 19,990 | D | — | — | (F1) Includes shares of common stock underlying unvested restricted stock units. |